Posterbeiträge 2022

 

 

Der VFTH e.V. präsentiert Forschungsergebnisse gewonnen aus Daten erfasst mit smart medication

 

 

"Efficacy of emicizumab prophylaxis in patients with severe hemophilia A in Germany: Real-life-data documented by eDiary smart medication" 

 

W. Mondorf, H. Eichler, C. Escuriola-Ettinghausen, R. Fischer, K. Holstein, R. Klamroth, U. Sachs

 

66th Annual Meeting of the Society of Thrombosis and Haemostasis Research, 01.-04.03.2022, Leipzig

Efficacy of emicizumab prophylaxis in patients with severe hemophilia A in Germany: Real-life-data documented by eDiary smart medication
W. Mondorf, H. Eichler, C. Escuriola-Ettinghausen, R. Fischer, K. Holstein, R. Klamroth, U. Sachs
GTH_2022_contribution163_Handout_VFTH_Em
Adobe Acrobat Dokument 384.2 KB

 

"Impact of lockdown on patients with severe hemophilia A during the Covid-19 pandemic in Germany on therapy and bleeding rates based on Real-life-data from smart medication" 

 

W. Mondorf, H. Eichler, C. Escuriola-Ettinghausen, R. Fischer, K. Holstein, R. Klamroth, H. Richter

 

66th Annual Meeting of the Society of Thrombosis and Haemostasis Research,01.-04.03.2022, Leipzig

Impact of lockdown on patients with severe hemophilia A during the Covid-19 pandemic in Germany on therapy and bleeding rates based on Real-life-data from smart medication
W. Mondorf, H. Eichler, C. Escuriola-Ettinghausen, R. Fischer, K. Holstein, R. Klamroth, H. Richter
Pain and treatment related to joint blee
Adobe Acrobat Dokument 1.4 MB